Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results

Author's Avatar
May 10, 2018
Article's Main Image

Core Businesses Driving Strong Financial Performance

CRINONE® Revenues Increased 30% and Juniper Pharma Services (JPS) Revenues Increased 55% Year-over-Year

Conference Call at 8:30 a.m. EDT Today

PR Newswire